University will host world’s first Covid-19 vaccine booster trials

booster

The world’s first Covid-19 vaccine booster jab is to be administered at the University of Bradford’s cutting-edge Digital Health Enterprise Zone on June 1. The jabs are being tested as a possible precaution against variants of the coronavirus, with the trial lasting one year. The trial is being conducted by Bradford Teaching Hospitals NHS Foundation […]

Read More… from University will host world’s first Covid-19 vaccine booster trials

Obesity: Lower bowel holds secret to weight loss

obesity

A human trial, supported by Bowel Research UK, has found that specific nutrients delivered to the colon can reduce food intake and may therefore be an important tool in tackling the nation’s obesity crisis and associated diseases, such as bowel cancer. The double-blind, randomised, placebo-controlled, crossover study was conducted amongst 20 volunteers with a body […]

Read More… from Obesity: Lower bowel holds secret to weight loss

Imperial COVID-19 vaccine trial expands to additional sites

trial

Imperial College London’s COVID-19 vaccine trial is expanding to additional sites throughout England.  From next week, the ground-breaking vaccine, which has received more donations, will be trialled in six additional centres. Preclinical studies have shown that the vaccine produced highly specific antibodies against SARS-CoV-2 in mice, which were able to neutralise the virus. The vaccine […]

Read More… from Imperial COVID-19 vaccine trial expands to additional sites

10 year radiotherapy results for breast cancer study

radiotherapy

Long-term safety of radiotherapy in fewer doses for patients with early breast cancer demonstrated in 10-year study A lower total dose of radiotherapy delivered in fewer but larger doses is as safe in the long term as breast cancer radiotherapy courses giving multiple small doses, according to the final results of a 10-year study. The findings […]

Read More… from 10 year radiotherapy results for breast cancer study